Long-term therapy of bipolar illness

Journal of Family Practice

Volumn 52, Issue 3 SUPPL., 2003, Pages 18-21

  Keck Jr , Paul E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; OLANZAPINE; VALPROIC ACID; BENZODIAZEPINE DERIVATIVE; DRUG DERIVATIVE; LITHIUM DERIVATIVE; NEUROLEPTIC AGENT; PIRENZEPINE; TRANQUILIZER; TRIAZINE DERIVATIVE;

BIPOLAR DISORDER; HUMAN; RECURRENCE RISK; RECURRENT DISEASE; REVIEW; AFFECT; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; PSYCHOLOGICAL ASPECT; TIME; TREATMENT OUTCOME;

AFFECT; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; CARBAMAZEPINE; CONTROLLED CLINICAL TRIALS; HUMANS; LITHIUM COMPOUNDS; PIRENZEPINE; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME; TRIAZINES; VALPROIC ACID;

EID: 0037338274     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Judd LL, Akiskal HS, Schettler PJ, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002;59:530-7.
2. Keck PE, Jr, McElroy SL. Treatment of bipolar disorder. In: Schatzberg AF, Nemeroff CB (eds). The American Psychiatric of Textbook of Psychopharmacology (3rd ed). Washington, DC: American Psychiatric Publishing (in press).
3. Hirschfeld RM, Bowden CL, Gitlin MJ, et al. Practice guideline for the treatment of patients with bipolar disorder (rev). Am J Psychiatry 2002;159(suppl):1-50.
4. Goodwin FK, Jamison KR. Manic-depressive illness. New York: Oxford University Press, 1990.
5. Frye MA, Gitlin MJ, Altshuler LL. Treating acute mania. Current Psychiatry 2003; 3(suppl 1):10-13.
6. Keck PE, Jr, McElroy SL, Nemeroff CB. Anticonvulsants in the treatment of bipolar disorder. J Neuropsychiatry Clin Neurosci 1992;4:395-405.
7. Dardennes R, Even C, Bange F, Heim A. Comparison of carbamazepine and lithium in prophylaxis of bipolar disorders. A meta-analysis. Br J Psychiatry 1995;166:378-81.
8. Denicoff KD, Smith-Jackson EE, Disney ER, Ali SO, Leverich GS, Post RM. Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. J Clin Psychiatry 1997;58:470-8.
9. Greil W, Ludwig-Mayerhofer W, Erazo N, et al. Lithium versus carbamazepine in the maintenance treatment of bipolar disorders: a randomised study. J Affect Disord 1997;43:151-61.
10. Kleindienst N, Greil W. Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study. Neuropsychobiology 2000;42(suppl I):2-10.
11. Lambert P, Venaud G. Comparative study of valpromide versus lithium in the treatment of effective disorders. Nervure 1992;5:57-62.
12. Bowden CL, Calabrese JR, McEIroy SL, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry 2000;57:481-9.
13. Tohen M, Baker RW, Altshuler LL, et al. Olanzapine versus divalproex in the treatment of acute mania. Am J Psychiatry 2002;159:1011-7.
14. Calabrese JR, Fatemi SH, Kujawa M, Woyshville MJ. Predictors of response to mood stabilizers. J Clin Psychopharmacol 1996;16(suppl I):S24-31.
15. Tohen M, Chengappa KNR, Suppes T, et al. Olanzapine combined with lithium or valproate in the prevention of recurrence in hipolar disorder: an 18-month study (paper presentation). Boston: U.S. Psychiatric and Mental Health Congress annual meeting, 2001.
16. Solomon DA, Ryan CE, Keitner GI, et al. A pilot study of lithium carbonate plus divalproex sodium for the continuation and maintenance treatment of patients with hipolar I disorder. J Clin Psydliatly 1997;58:95-9.
17. Tohen M, Marneros A, Bowden CL, et al. Olanzapine versus lithium in relapse prevention in bipolar disorder: a randomized double-blind controlled 12-month clinical trial (paper presentation). Freiburg, Germany: European Stanley Foundation Bipolar Conference, 2002.
18. Sanger TM, Grundy SL, Gibson PJ, Namjoshi MA, Greaney MG, Tohen MF. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study. J Clin Psychiatry 2001;62:273-81.
19. Calabrese JR, Shelton MD, Rapport DJ, Kimmel SE, Ellraj O. Long-term treatment of bipolar disorder with lamotrigine. J Clin Psychiatry 2002:63(suppl I0):18-22.
20. Bowden CL. Lamotrigine in the treatment of bipolar disorder. Expert Opin Pharmacother 2002;3:1513-9.